The importance of the indirect pathway of allorecognition in clinical transplantation.
The immune system mounts a response to non-self transplanted tissue through a number of mechanisms. The indirect pathway of allorecognition, in which cells of the adaptive immune system recognize MHC alloantigen-derived peptide on self-MHC molecules, has emerged as a potent inducer of allograft rejection. In particular, recent evidence convincingly connects the indirect pathway with chronic rejection, including antibody-mediated and CD8(+) T cell-mediated rejection. However, the indirect pathway can also promote the generation of regulatory T cells, which have emerged as crucial suppressors of the alloresponse, and hold much promise in the quest for clinical tolerance. An improved understanding of the indirect pathway is likely to bring important benefits to transplant recipients.
Gökmen
M Refik
MR
Immunoregulation Laboratory, King's College London, 5th Floor, Southwark Wing, Guy's Hospital, Great Maze Pond, London SE1 9RT, United Kingdom. refik.gokmen@kcl.ac.uk
Lombardi
Giovanna
G
Lechler
Robert I
RI
D000818:Animals; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology / Q000378:metabolism; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology / Q000378:metabolism; D006084:Graft Rejection / Q000276:immunology*; D006649:Histocompatibility Antigens / Q000276:immunology* / Q000378:metabolism; D006801:Humans; D007108:Immune Tolerance / Q000276:immunology*; D007519:Isoantigens / Q000276:immunology; D050378:T-Lymphocytes, Regulatory / Q000276:immunology* / Q000378:metabolism; D014181:Transplantation Immunology; D014184:Transplantation, Homologous / Q000276:immunology
D006649:Histocompatibility Antigens; D007519:Isoantigens